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Background: To describe T-cell and natural killer (NK) cell phenotypes within nursing home elderly.
Methods: Nursing home elderly were recruited from four nursing homes in Hamilton, Ontario between September
2010 and December 2011. Healthy adults were recruited from McMaster University between September 2011 and
December 2011. Nursing home elderly ≥65 years were eligible; those on immunosuppressive medications were
excluded. Healthy adults ≥18-64 years were eligible. CD8+ and CD4+ T-cells% and their subsets, T-regs% and NK
cell subset% were compared between the nursing home elderly and healthy adults.
Results: 262 nursing home elderly were enrolled; median age 87 years and 81% were female. 16 healthy adults were
enrolled; median age 31 and 50% were female. There was no significant difference between CD8+ T-cell% in nursing
home and healthy adults (median 17.1 versus 18.0, p = 0.56), however there were fewer naïve CD8 + T-cell% (median
0.9 versus 5.2, p < 0.001), more terminally differentiated CD8 + T-cell% (median 7.3 versus 4.1, p = 0.004) and more
senescent T-cell% (median 5.3 versus 3.1, p = 0.04) in the nursing home elderly. There were more CD4+ T-cell% in the
nursing home elderly compared to healthy adults (median 45.5 versus 37.1, p = 0.001). Nursing home elderly had a
higher CD4+/CD8+ ratio than healthy adults (2.6 versus 1.9, p = 0.048), higher T-reg% (median 1.8 versus 0.8, p < 0.001)
and increased mature NK cell% (median 12.1 versus 5.4, p = 0.001) compared to healthy adults.
Conclusion: Differences in naïve CD8+ T-cells, terminally differentiated and senescent CD8+ T-cells, T-regs and NK cell
subsets were similar to studies involving community dwelling elderly. In contrast, the CD4+/CD8+ ratio was higher in
nursing home elderly.
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Dysfunctional changes to the immune system that arise
with age are termed immunosenescence [1]. Although all
components of the immune system are affected by aging,
changes to T-cells are by far the most pronounced [1].
Changes include a reduction in the number of naïve T-
cells due to thymic involution, and an increase in CD8+
memory T-cells subsets including an accumulation of ter-
minally differentiated memory T-cells (CD8 + CD45 +
CCR7-) [2] and senescent cells (CD8 + CD28-) [3,4]. These
changes have led to the identification of immune bio-
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article, unless otherwise stated.vaccine failure in two community dwelling elderly co-
horts [5,6] and an immune risk profile characterized by
a CD4+/CD8+ ratio less than 1 (due to the expansion of
the CD8+ T-cell pool relative to CD4+ T-cell pool) was
predictive of both mortality and chronic infection with
cytomegalovirus (CMV) in aging Swedish cohorts [4,7-9].
The nursing home elderly are a group that are at high
risk of infection, vaccine failure and mortality, and it is pos-
tulated that immunosenescence is associated with this in-
creased risk [10]. However, immune phenotypes in this
group have not been well characterized, as most immuno-
senescence studies have excluded the nursing home elderly
[10]. Three studies have investigated the immune pheno-
type of peripheral blood mononuclear cells (PBMCs) in the
nursing home elderly [3,11,12]; two of these reports con-
tained an elderly population composed of community
dwelling and nursing home elderly and did not report spe-
cifically on the latter group [11,12], whereas the other studytral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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observations from these studies concluded that the nursing
home elderly displayed immunosenescent phenotypes simi-
lar to the community dwelling elderly. However, it remains
unclear whether immune phenotypes in the nursing home
elderly are influenced by frailty and malnutrition; two con-
ditions that are present in the nursing home elderly
[13,14] and thought to influence immunosenescence
[15-17]. Furthermore, the changes to a separate class of
T-cell, the regulatory CD4+ T-cell (T-reg) and to the in-
nate immune natural killer (NK) cell subsets have not
yet been described in the nursing home elderly. The
goal of this study therefore was to characterize T-cell
and NK cell subsets within the nursing home elderly as
a precursor to the identification of candidate immune
biomarkers.
To this end, we examined circulating CD4+ and CD8+
T-cells and T-cell subsets (naïve, central memory, effector
memory, terminally differentiated and senescent T-cells),
T-regs and NK cell subset (immature, mature and senes-
cent NK cells) in the nursing home elderly compared to
healthy adults, and explored how individual immune phe-
notypes were influenced by age, sex, frailty and nutritional
status in the nursing home elderly.Methods
Subjects and setting
Elderly participants were recruited from four nursing
homes in Hamilton, Ontario between September 2010
and December 2011. Nursing home residents ≥65 years
were eligible. Residents on immunosuppressive medica-
tions (including cancer chemotherapy, oral corticosteroid
use >21 days, methotrexate, post-transplant medications
and/or anti-cytokine or B-lymphocyte depletion therapies)
were excluded, as were participants affected by serious dis-
eases with very poor short-term prognosis (as determined
by the supervising physician). Written informed consent
was obtained for all participants. A convenience sample of
healthy adult participants (≥18 years and <65 years) were
recruited from McMaster University in Hamilton, Ontario
between September and December 2011. Healthy adults
were laboratory students and staff who responded to an
advertised request by the study investigators for partici-
pants. The study had Research Ethics Board approval from
Hamilton Health Sciences and McMaster University
Health Sciences ethics boards.
A research nurse abstracted baseline demographics
from the nursing home elderly based on participant
interview, examination and chart review. Frailty was
rated according to the Clinical Frailty Scale, an 8-point
scale ranging from very fit (1) to very severely frail (8),
which has been validated in the nursing home popula-
tion [13]. Nutritional status was assessed using theMini Nutritional Assessment which categorized resi-
dents as having normal nutritional status, being at risk
of malnutrition or malnourished [14].
Whole blood analysis and flow cytometry
Whole blood was obtained from participants between
7 am and 10 am and hand delivered to the research la-
boratory for immediate processing. An aliquot of whole
blood was used for phenotyping. T-cell phenotypes were
determined by staining PBMCs in round-bottom 96-well
plates with anti-CD3-Qdot605, anti-CD8-Alexa Flour 700,
anti-CD4-Pacific Blue, anti-CD45RA-PE Texas Red, anti-
CD28-PE, anti-CD57-FITC, anti-CCR7-PE Cy7. T-regs
were identified using anti-CD3-FITC, anti-CD4-Pacific
Blue, anti-CD127-PerCP-Cy5.5, anti-CD25-PE, and anti-
FoxP3-AlexaFluor700. NK phenotypes were determined by
staining PBMCs with anti-CD3-FITC, anti-CD56-PECy7
and anti-CD16-AlexaFluor700. The following antibodies
were purchased from BD Bioscience: anti-CD4-Pacific Blue,
anti-CD28-PE, anti-CCR7-PE-Cy7, anti-CD25-PE, anti-
CD56-PE-Cy7, and anti-CD16-AlexaFluor700. The follow-
ing antibodies were purchased from eBioscience: anti-CD3-
FITC, anti-CD127-PerCP-Cy5.5, anti-FoxP3-AlexaFluor700.
The anti-CD3-Qdot605 was purchased from Invitrogen.
The anti-CD57-FITC and anti-CD45RA-PE-TexasRed anti-
bodies were purchased from Beckman Coulter. We defined
the T-cell subsets as follows: naïve (CD45 +CCR7+), central
memory (CD45-CCR7+), effector memory (CD45-CCR7-),
terminally differentiated (CD45 +CCR7-) and senescent
(CD28-CD57+). T-regs were defined as CD4 +CD25hiC-
D127loFoxp3+. NK cells were determined based on CD16
and CD56 expression. CD56brightCD16- were classified as
immature NK cells, CD56dimCD16+ were classified as ma-
ture NK cells, and a recently described NK cell subset,
CD56dimCD16-, was classified as senescent NK cells [18].
CD4+ and CD8+ immune phenotypes, T-regs and NK cell
subsets were expressed as a percentage of total lymphocytes.
Antibody staining was performed using a Beckman
Coulter Biomek NXp Laboratory Automation Workstation
(Beckman Coulter, Ontario) as described in our recent
publication [19], followed by analysis using an LSR II flow
cytometer with a high-throughput sampler (BD Biosci-
ences, NJ, USA), and data was analyzed using FlowJo 9.6
(Treestar Inc, Ashland, OR).
PBMCs were isolated and frozen using a validated com-
mon standard operating procedure [20]. PBMCs were
thawed and CMV-reactive T-cells were identified by stimu-
lating PBMCs with a pool of overlapping peptides spanning
the immunodominant pp65 protein of CMV (PepTivator
pp65, Miltenyi Biotec) according to our published proto-
cols [21]. Briefly, thawed PBMCs were cultured overnight
at 37°C and stimulated with CMV peptides (2 ug/ml) for
1 hr at 37°C. A matched set of PBMCs were stimulated
with DMSO as a negative control. Brefeldin A (BD
Table 1 Baseline characteristics of the nursing home
elderly and healthy adults
Baseline characteristics Nursing home
elderly n = 262
Healthy adults
n = 16
n (%) n (%)
Age (years)
18-24 - 2 (13)
25-34 - 9 (56)
35-44 - 4 (25)
45-54 - 1 (6)
55-64 - 0 (0)
65-74 21 (8) -
75-84 73 (28) -
85-94 147 (56) -
≥95 21 (8) -
Sex (F) 213 (81) 8 (50)
Any co-morbidity 245 (94) 0 (0)
Diabetes 75 (29) -
Stroke 56 (21) -
Heart failure 36 (14) -
Coronary artery disease 81 (31) -
Cancer 21 (8) -
COPD 30 (11) -
Dementia 137 (52) -
≥5 medications 229 (87) 0 (0)
Nutritional status
At risk of malnutrition 121 (46) 0 (0)
Malnourished 13 (5) 0 (0)
Frailty
4 64 (24) 0 (0)
5 62 (24) 0 (0)
6 94 (36) 0 (0)
7 38 (15) 0 (0)
8 4 (1.5) 0 (0)
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turer’s instructions and the cells were incubated for an
additional 4 hours. The cells were stained with anti-CD4-
PacificBlue and anti-CD8-AlexaFluor700, permeabilized
and finally stained with anti-IFN-γ-APC, anti-TNF-α-FITC
and anti-CD3-QDot605. CMV-reactive T-cells were identi-
fied as CD3+ (CD4+ or CD8+) IFN-γ +TNF-α + .
Data analysis
Many of the immune phenotype distributions were
skewed thus the results were summarized as medians and
interquartile ranges (IQR). Non-parametric tests of signifi-
cance were used including Mann–Whitney U, Kruskal-
Wallis and Spearman’s rank correlation as appropriate. All




In total, 262 nursing home elderly were enrolled; ages
ranged from 65 – 98 years, median age was 87 years
(IQR 82–91) and 81% were female. The majority (94%)
had at least one co-morbidity, and over half (52%) had a
diagnosis of dementia (Table 1). Sixty percent of the par-
ticipants scored 5 or 6 on the Clinical Frailty Scale, cat-
egorizing them as either mildly frail or moderately frail
[13] (Table 1) and the median frailty according to the Clin-
ical Frailty Scale was 6 (IQR 5–6), [13]. Sixteen healthy
adults were enrolled; median age was 31 (IQR 27–36) and
50% were female (Table 1).
Description of immune phenotypes
There was no significant difference between the medians
of CD8+ T-cell% in the nursing home elderly and healthy
adults (median 17.1 versus 18.0, p = 0.56), however there
was a significantly lower naïve CD8+ T-cell% median in
the nursing home elderly compared to healthy adults (me-
dian 0.9 versus 5.2, p < 0.001), significantly higher termin-
ally differentiated CD8+ T-cell% median in the nursing
home elderly compared to healthy adults (median 7.3 ver-
sus 4.1, p = 0.004) and significantly higher CD8+ senescent
T-cell% median in the nursing home elderly group when
compared to the healthy adults (median 5.3 versus 3.1,
p = 0.04) (Table 2).
There was a significantly higher CD4+ T-cell% median
in the nursing home elderly compared to healthy adults
(median 45.5 versus 37.1, p = 0.001) (Table 2). The overall
increase in CD4 + % appeared due to higher central mem-
ory T-cell% and effector memory T-cell% in the nursing
home elderly when compared to healthy adults (central
memory% median 12.6 versus 8.4, p = 0.003 and effector
memory% median 18.6 versus 12.3, p < 0.001) but not the
terminally differentiated memory CD4+ T-cell% in the
nursing home elderly when compared to healthy adults(median 1.8 versus 1.2, p = 0.09) (Table 2). In the nursing
home elderly, females had higher median CD4 +% than
males (median 46.1 versus 42.1, p = 0.02), higher median
naïve CD4 T-cell% (median 10.1 versus 7.1, p = 0.04) and
higher median terminally differentiated CD4+ T-cell%
(median 1.9 versus 1.4, p = 0.03) (Table 3).
There was significantly higher median T-reg% in the
nursing home elderly group when compared to the
healthy adults (median 1.8 versus 0.8, p < 0.001) (Table 2).
In the nursing home elderly, there were significant differ-
ences in median T-regs% across frailty (p < 0.001) and nu-
tritional status (p < 0.001) (Table 3).
When the CD4+/CD8+ T-cell ratios were compared,
the nursing home elderly had a higher CD4+/CD8+ T-cell
Table 2 Immune phenotypes in the nursing home elderly compared to healthy adults
Immune phenotype Nursing home elderly Healthy adults p-value*
Median (IQR) Median (IQR)
n = 262 n = 16
CD8+
CD8 + % 17.1 (11.9 – 23.9) 18.0 (15.1 – 21.0) 0.56
Naïve CD8 + % 0.90 (0.5 – 1.4) 5.2 (3.8 – 7.9) <0.001
Central memory CD8 + % 0.6 (0.3 – 1.0) 0.5 (0.4 – 0.8) 0.86
Effector memory CD8 + % 6.3 (3.9 – 9.4) 8.1 (6.6 – 10.1) 0.14
Terminally differentiated CD8 + % 7.3 (3.5 – 12.5) 4.1 (2.0 – 6.0) 0.004
Senescent CD8 + % 5.3 (2.2 – 9.4) 3.1 (0.7 – 6.2) 0.04
CD4+
CD4 + % 45.5 (38.0 - 52.7) 37.1 (29.7 - 43.1) 0.001
Naïve CD4 + % 9.2 (5.1 – 13.7) 11.6 (7.1 - 15.4) 0.19
Central memory CD4 + % 12.6 (9.1 - 16.2) 8.4 (6.5 - 13.2) 0.003
Effector memory CD4 + % 18.6 (14.1 - 22.6) 12.3 (11.8 - 15.8) <0.001
Terminally differentiated CD4 + % 1.8 (1.1 – 2.8) 1.2 (0.6 - 2.1) 0.09
Senescent CD4 + % 1.4 (0.2 - 3.4) 0.8 (0.1-2.0) 0.21
T-reg
T-reg% 1.8 (1.1 – 2.6) 0.8 (0.6 – 0.9) <0.001
Ratio
CD4 + : CD 8 + ratio 2.6 (1.7 – 4.1) 1.9 (1.6 – 2.6) 0.048
NK
Mature NK cell% 12.1 (7.9 – 16.6) 5.4 (2.7 – 10.0) 0.001
Senescent NK cell% 1.4 (0.89 – 2.2) 1.7 (1.5 – 2.6) 0.27
Immature NK cell% 0.2 (0.1 – 0.4) 0.3 (0.04 – 0.7) 0.57
*Mann–Whitney U test of significance used.
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2.6 versus 1.9, p = 0.048) (Table 2). In the nursing home
elderly, the CD4+/CD8+ ratio ranged from 0.42 – 22 and
only 17 (6.5%) had a CD4+/CD8+ ratio <1.0. This was in
contrast to a far narrower range of values in the healthy
adults (CD4+/CD8+ ratio range 1.1 – 3.5). In the nurs-
ing home elderly, age, sex, frailty and nutritional status
were not associated with changes to the CD4+/CD8+
ratio (Table 3).
There was an increase in the mature NK cell% in the
nursing home elderly compared to the healthy adults
(median 12.1 versus 5.4, p = 0.001) and no significant
difference between senescent NK cell% (median 1.4
versus 1.7, p = 0.27) or immature NK cell% (median 0.2
versus 0.3, p = 0.57) (Table 2). In the nursing home eld-
erly, higher senescent NK cell% was associated with in-
creasing frailty (p < 0.001) and worsening nutrition
(p = 0.01) (Table 3). Age, sex, frailty and nutrition did
not appear to have a significant association with ma-
ture or immature NK cells (Table 3).
Of the 262 nursing home elderly enrolled in the study,
242 had PBMCs available for assessment of T-cellimmunity to CMV. In total, 217/242 (90%) of individuals
had evidence of prior CMV infection.
Discussion
In this crosssectional study in the nursing home elderly,
we observed 1) lower naïve CD8+ T-cells and higher
terminally differentiated and senescent CD8+ T-cells; 2)
higher CD4+ T-cells driven by central and effector mem-
ory CD4+ T-cells; 3) higher CD4+/CD8+ T-cell ratio; 4)
higher T-regs; and 5) higher mature NK cells and when
compared to healthy adults.
The lower naïve CD8+ T-cells and higher terminally dif-
ferentiated CD8+ T-cells seen in this study in the nursing
home elderly has been well described in community dwell-
ing elderly [2,3,22]. These differences are consistent with
existing dogma, that the remodelling of the T-cell com-
partment seen with advanced age is due to a decrease in
naïve T-cells due to thymic involution and an increase in
terminally differentiated T-cells, possibly due to chronic
antigenic stimulation from CMV [1]. Indeed, 90% of the
elderly nursing home residents in our study had evidence
of CMV immunity, consistent with prior studies where
Table 3 Immune phenotypes as a function of age, sex, frailty and nutritional status
Immune phenotype Age Correlation+




























CD8 + % 0.05 17.1 17.4 18.6 17.6 16.3 16.3 17.4 17.1 17.1
(11.8-24.2) (12.8-22.2) (13.7-23.8) (12.3-21.9) (11.7-24.1) (9.7-26.8) (12.2-23.8) (11.7-24.2) (11.2-20.9)
Naïve CD8 + % −0.13* 0.9 0.8 0.9 0.8 1.0 1.2 0.9 1.0 0.7
(0.5-1.5) (0.4-1.2) (0.5-1.4) (0.5-1.4) (0.5-1.4) (0.5-2.1) (0.5-1.4) (0.58-1.6) (0.3-1.2)
Central memory CD8 + % −0.03 0.6 0.5 0.5 0.5 0.6 0.7 0.5 0.7 0.5
(0.3-1.0) (0.3-0.8) (0.3-0.9) (0.3-0.9) (0.3-1.0) (0.3-1.5) (0.3-0.9) (0.3-1.1) (0.4-0.9)
Effector memory CD8 + % −0.04 6.1 7.1 6.7 6.3 6.3 5.7 6.5 6.0 6.0
(3.8-9.5) (4.5-9.7) (4.1-9.9) (4.1-8.7) (3.7-10.0) (4.0-8.6) (3.8-9.9) (3.9-8.8) (4.0-10.9)
Terminally differentiated CD8 + % 0.08 7.8 5.9 8.9 7.6 6.9 6.1 8.1 7.2 5.8
(3.6-12.6) (3.3-12.5) (4.2-13.3) (3.7-12.8) (3.4-11.0) (2.4-12.9) (3.5-12.7) (3.6-12.5) (3.1-10.9)
Senescent CD8 + % 0.04 5.1 5.7 6.2 5.0 5.1 4.9 5.1 5.2 5.6
(2.3-8.9) (2.0-11.3) (2.8-11.4) (2.3-9.3) (2.2-7.9) (0.8-10.0) (2.2-10.0) (2.3-8.6) (1.2-9.5)
CD4+
CD4 + % −0.06 46.1* 42.1* 44.9 45.8 46.4 43.1 46.1 45.8 42.0
(39.1-53.8) (34.7-49.1) (38.6-53.6) (37.1-52.6) (40.4-53.1) (32.4-52.7) (38.7-52.6) (36.1-53.5) (35.9-44.9)
Naïve CD4 + % 0.05 10.1* 7.1* 10.5 9.2 9.3 7.2 10.4* 8.7* 5.9*
(5.4-14.6) (4.6-11.5) (5.4-18.0) (5.3-14.7) (5.4-13.1) (4.0-12.2) (5.4-16.1) (4.8-12.5) (3.4-9.9)
Central memory CD4 + % −0.08 12.8 11.7 12.5 12.0 13.3 12.8 12.5 13.1 10.7
(9.6-16.4) (8.7-14.6) (9.0-15.4) (8.4-16.2) (10.7-18.2) (8.7-15.8) (9.2-16.2) (9.0-17.2) (9.3-13.3)
Effector memory CD4 + % 0.13* 18.9 18.2 19.3 18.1 19.2 17.0 18.6 19.0 18.5
(14.6-23.0) (12.9-21.4) (13.6-21.8) (12.7-21.9) (15.2-24.2) (13.5-22.4) (13.5-21.8) (14.6-22.8) (12.8-26.6)
Terminally differentiated CD4 + % 0.05 1.9* 1.4* 1.9 1.8 1.6 1.8 1.9 1.6 1.4
(1.1-2.9) (0.6-2.5) (1.1-3.3) (1.1-2.6) (1.1-2.7) (0.8-2.7) (1.1-2.9) (1.0-2.8) (0.9-2.0)
Senescent CD4 + % 0.11 1.4 1.3 1.5 1.4 1.4 1.2 1.4 1.3 2.0
(0.3-3.5) (0.2-2.9) (0.3-4.2) (0.1-3.1) (0.3-3.6) (0.2-2.9) (0.16-3.4) (0.27-3.2) (0.34-4.4)
T-reg
T-reg% 0.08 1.8 1.6 2.5 ** 2.0** 1.6** 1.0** 2.2** 1.6** 1.0**


















Table 3 Immune phenotypes as a function of age, sex, frailty and nutritional status (Continued)
Ratio
CD4 + : CD 8 + ratio −0.06 2.6 2.5 2.5 2.4 2.7 2.6 2.6 2.6 2.3
(1.7-4.5) (1.6-3.5) (1.6-3.8) (1.8-4.1) (1.9-4.5) (1.4-5.0) (1.7-4.1) (1.6-4.5) (1.8-3.3)
NK
Mature NK cell% −0.05 12 12.6 12.0 11.3 12.3 12.7 12.3 11.6 14.7
(8.0-16.6) (7.1-17) (8.3-6.3) (7.1-15.2) (7.3-16.7) (8.5-17.2) (8.7-16.0) (6.8-16.5) (7.9-18.4)
Senescent NK cell% −0.10 1.4 1.5 1.0** 1.1** 1.7** 2.0** 1.3* 1.6* 1.4*
(0.9-2.2) (1.0-2.4) (0.7-1.9) (0.7-1.9) (1.0-2.7) (1.3-2.7) (0.74-2.1) (1.0-2.7) (1.1-2.3)
Immature NK cell% 0.03 0.2 0.3 0.2 0.21 0.3 0.3 0.2 0.2 0.2
(0.1-0.4) (0.1-0.5) (0.1-0.4) (0.1-0.3) (0.2-0.4) (0.2-0.4) (0.2-0.4) (0.1-0.4) (0.13-0.45)
*p ≤ 0.05.
**p ≤ 0.001.
aOne patient excluded as nutritional status unknown.
+Spearman’s rank test of significance used.
++Mann–Whitney U test of significance used.
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of those aged over 80 years [23]. The reduction of naïve T-
cells is thought to impair the ability of the host to respond
against novel pathogens [10,24] and the terminally dif-
ferentiated memory T-cells are considered to have poor
functionality resulting in impaired responses to recall
antigens [24], supporting the hypothesis that these im-
mune changes increase the risk of infection and mortal-
ity in the elderly.
Higher senescent CD8 + CD28- T-cells have been asso-
ciated with advancing age [3,4], influenza vaccine failure
[5,6] and CMV infection [4]. In this study, there was a
higher median senescent CD8+ T-cells in the nursing
home elderly when compared to healthy adults. The one
prior immunosenescence study performed in the nursing
home elderly also reported higher senescent T-cells when
compared to healthy adults [3].
The described differences in CD4+ T-cells in the elderly
have been far more inconsistent than for CD8+ T-cells.
Studies have described both higher CD4+ T-cells [25,26]
and lower CD4+ T-cells [2,4,9,27,28]. Two studies found
lower CD4+ T-cells in malnourished elderly [16,17] and
the one study that enrolled exclusively nursing home resi-
dents showed no change at all [3]. It is possible, that the
higher CD4 +% seen in our study is partially explained by
the predominance of females in the nursing home group
(81%), as females had higher CD4% than men, a finding
consistent with the literature [25]. The high proportion of
females enrolled in our study in the nursing home elderly
group was expected given that nursing homes in Canada
are comprised of approximately 70% females [29]. Our
CD4 + T-cell subset results, that the higher circulating
CD4+ T-cells in the nursing home elderly was due to
higher central memory and effector memory T-cells, are
consistent with another immunosenescence study that
enrolled community elderly and used newer immune
phenotyping better able to delineate the naïve and
memory T-cells pools [2].
The expanded CD4+ T-cell compartment in the nursing
home elderly in our study is likely why the CD4+/CD8+
T-cell ratio was higher in the nursing home elderly group
than the healthy elderly and only 6% of the nursing home
elderly had a CD4+/CD8+ ratio <1.0. This is in contrast to
the Swedish OCTO (n = 102) and NONA (n = 138) co-
horts where 14% and 20% of the cohorts had CD4+/CD8+
ratios <1.0 [4,7]. Our results are very similar to another
study that included exclusively nursing home elderly (n =
116); the CD4+/CD8+ ratio was 2.0 in the elderly and
1.7 in the young cohort (the difference was not signifi-
cant, p = 0.64) [3]. In a Spanish study that enrolled 151
elderly people ≥65 years only 7.9% of the cohort had a
CD4+/CD8+ T-cell ratio <1.0 [30]. The reason for the
discrepancy in results among the studies is not clear,
but could relate to differences in population. First, only34% in the NONA cohort were in institutional care [4]
versus 100% in our study. Second, the proportion of fe-
males enrolled could influence the CD4+/CD8+ ratio given
the noted association between female sex and CD4 + %.
Both our study and the other study that included exclu-
sively nursing home elderly were comprised of approxi-
mately 80% females [3] whereas the OCTO and NONA
studies consisted of 65% and 70% females, respectively
[31]. Last, the OCTO and NONA studies were conducted
in Sweden whereas this and the other nursing home study
are North American [3]. Indeed, 8% of younger adults in
Sweden (ages 20–59) have a CD4+/CD8+ T-cell ratio <1.0
[31]. The NONA cohort has also demonstrated that at
very advanced ages (>90 years), it is possible to move from
having a CD4+/CD8+ T-cell ratio <1.0 to above 1.0, which
is another possible reason why our study had so few
people with CD4+/CD8+ T-cell ratios <1.0 [8]. Our find-
ings raise the possibility that CD4+/CD8+ ratios <1.0 may
not be predictive of increased mortality in the nursing
home elderly, particularly given that this ratio tended to
increase in residents with severe frailty.
The accumulation of T-regs has been consistently
observed in studies of aging involving the community
elderly [32]. How higher T-regs could lead to impairment of
host control of infection is not clear, but may be secondary
to a decreased ability of aged T-regs to proliferate and pro-
duce cytokines [33]. It is interesting to note that the median
T-regs% was lower in healthy adults when compared to
nursing home elderly, but also in the very frail and the
malnourished nursing home elderly. To our knowledge, no
other study has reported on the relationship between T-regs
and frailty or nutrition. Further study into the relationship
between T-regs and human immunosenescence is required.
The higher mature NK subset seen in the nursing
home elderly in our study is consistent with immunose-
nescence studies including community dwelling elderly
[34,35]. These results support the observation that the
increase in NK cells seen in the elderly is due to accu-
mulation of mature NK cells. We speculate that the
higher numbers of mature NK cells could be due to the
same mechanism leading to higher numbers of memory
T-cells in the elderly; chronic antigenic stimulation [1].
Although the medians of the recently described senes-
cent NK cells [18] did not differ between the nursing
home elderly and the healthy adults, there was higher
senescent NK cell medians in those with advancing
frailty and worsening nutrition.
Although our study has many strengths including a large
sample size of nursing home residents and detailed clinical
information including frailty and nutritional status as well
as comprehensive immune phenotyping, limitations of our
study include the small size of the comparator group,
which may have increased our risk of not finding a differ-
ence between the two groups when one exists (type II
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to at least four other similar studies where the control
group size ranged from 15 to 21 adults [3,8,36,37] and
our findings were similar to studies involving commu-
nity dwelling elderly, increasing the confidence in our
results. In addition, due to our study design, we are un-
able to conclude that the observed differences in im-
mune phenotypes between the nursing home elderly
and healthy adults are necessarily associated with aging.
However, the goal of this study was not to determine as-
sociations, but to characterize differences in T-cell and
NK cell subsets in the nursing home elderly, to aid in
the identification of immune biomarkers in future stud-
ies involving the nursing home elderly.
Conclusion
Differences in naïve CD8+ T-cells, terminally differenti-
ated CD8+ T-cells, T-regs and NK cells subsets in the
nursing home elderly were similar to studies involving
community dwelling elderly. However, the CD4+/CD8+
T-cell ratio was higher in our study population. These re-
sults will aid future studies designed to investigate im-
mune biomarkers predictive of infection, vaccine failure
and mortality in the nursing home elderly.
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